Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Institution: Peter MacCallum Cancer Centre and Royal Melbourne ASH 2022

Institution: Peter MacCallum Cancer Centre and Royal Melbourne ASH 2022

Rationale for combining ibrutinib with tisa-cel in MCL 1:13
Rationale for combining ibrutinib with tisa-cel in MCL
Adrian Minson • 11 Dec 2022
The promise of bispecific antibodies in the treatment of NHL 1:17
The promise of bispecific antibodies in the treatment of NHL
Adrian Minson • 11 Dec 2022
The content of VJHemOnc is intended for healthcare professionals